Diagnostic Model Based on Delayed Post-Gadolinium Enhancement MRI Accurate for Meniere Disease
By Elana Gotkine HealthDay Reporter
TUESDAY, July 15, 2025 -- A diagnostic model based on delayed post-gadolinium enhancement magnetic resonance imaging (DEMRI) improves the accuracy of Meniere disease (MD) diagnosis, according to a study published online July 8 in Diagnostic and Interventional Radiology.
Xinyi Chen, from The Second Affiliated Hospital in Hangzhou, China, and colleagues examined the diagnostic performance of DEMRI for MD in a retrospective multicenter study conducted in patients presenting with Menieriform symptoms. A total of 162 ears were included: 95 with MD and 67 controls. Each ear was randomly assigned to the training set or validation set (98 and 64, respectively). Diagnostic models for MD were developed using logistic regression in the training cohort. Diagnostic performance of different models was examined using the area under the curve (AUC), and AUC estimates were compared between models using the Delong test.
The researchers found that in both the training and validation cohorts, the proposed DEMRI diagnostic model demonstrated strong diagnostic performance (AUC, 0.907 and 0.887, respectively), outperforming the clinical diagnostic model in the validation cohort (P = 0.01231). Although the difference was not statistically significant, the AUC of the DEMRI model was also higher than that of the combined DEMRI-clinical model (AUC, 0.796; P = 0.054). The sensitivity and specificity of the DEMRI model were 78.9 and 88.5 percent, respectively, in the training set.
"We recommend DEMRI when MD is suspected due to its substantial diagnostic potential," the authors write. "Further studies are needed to explore the broader applicability of our model and support its clinical implementation."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
AAP Updates Screening Guidance for Child Mental Health, Behavioral Problems
MONDAY, Aug. 25, 2025 -- In a clinical report issued by the American Academy of Pediatrics and published online Aug. 25 in Pediatrics, updated recommendations are presented for...
Discordance Seen Between Care Goals, Treatment Intent in Advanced Cancer
MONDAY, Aug. 25, 2025 -- More patients with advanced cancer report that their treatment discordantly focuses on longevity over comfort than patients with other illnesses...
Apitegromab Improves Motor Function in Spinal Muscular Atrophy
MONDAY, Aug. 25, 2025 -- For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhibits myostatin activation, improves...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.